Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease

This study has been completed.
Information provided by:
Alba Therapeutics Identifier:
First received: June 25, 2007
Last updated: January 18, 2010
Last verified: January 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)